em 523 has been researched along with candesartan cilexetil in 1 studies
Studies (em 523) | Trials (em 523) | Recent Studies (post-2010) (em 523) | Studies (candesartan cilexetil) | Trials (candesartan cilexetil) | Recent Studies (post-2010) (candesartan cilexetil) |
---|---|---|---|---|---|
26 | 1 | 0 | 628 | 151 | 133 |
Protein | Taxonomy | em 523 (IC50) | candesartan cilexetil (IC50) |
---|---|---|---|
Type-1 angiotensin II receptor | Oryctolagus cuniculus (rabbit) | 0.2 | |
Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 2.4547 | |
DNA polymerase kappa | Homo sapiens (human) | 7.4 | |
DNA polymerase iota | Homo sapiens (human) | 6.2 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 5 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 0.7244 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tanaka, H | 1 |
1 review(s) available for em 523 and candesartan cilexetil
Article | Year |
---|---|
[Receptor agonists and antagonists: the present and future].
Topics: Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Benzodiazepinones; Biphenyl Compounds; Cholinergic Antagonists; Devazepide; Erythromycin; Imidazoles; Ligands; Losartan; Peptides; Receptors, Cholecystokinin; Receptors, Gastrointestinal Hormone; Receptors, Neuropeptide; Tetrazoles | 1993 |